Brief: Control Bionics Sees FY27 Revenue Growth Of 50% Over FY26
28/08/2026 01:43
BRIEF-Control Bionics Sees FY27 Revenue Growth Of 50% Over FY26 Aug 28 (Reuters) - Control Bionics Ltd CBL.AX:
SEES FY27 REVENUE GROWTH OF 50% OVER FY26
Further company coverage: CBL.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Control Bionics
See all newsBrief: Control Bionics Posts Full-Year Loss Attributable Of A$7.3 Million
Brief: Control Bionics Sees FY27 Revenue Growth Of 50% Over FY26
Brief: Control Bionics Says Medicare Billing Code Secured For Nextlevel Speech Devices
Brief: Control Bionics Receives UK MHRA Registration For Neurostrip
Australia's Control Bionics jumps after FDA listing for NeuroStrip device